Insider Transactions Reported by 8 Insiders of Viking Therapeutics, Inc.

Symbol
VKTX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Viking Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian Lian President & CEO, Director $84,687,925 -$10,426,157 -11% 27 Oct 2025
Marianna Mancini Chief Operating Officer $13,387,377 -$2,652,564 -17% 27 Oct 2025
GREG ZANTE Chief Financial Officer $6,075,876 -$2,485,504 -29% 27 Oct 2025
LAWSON MACARTNEY Director $3,293,598 02 Jan 2025
Charles A. Rowland Jr Director $1,067,139 -$2,134,278 -67% 27 Oct 2025
MATTHEW W. FOEHR Director $1,056,288 11 Apr 2025
J. MATTHEW SINGLETON Director $755,250 02 Jan 2025
Sarah Kathryn Rouan Director $29,943 +$29,943 31 Mar 2025

Recent Insider Transactions by Companies or Individuals for Viking Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.